DARPA’s approach to solving this is the Blue Angel program. Started in response to the 2009 H1N1 swine flu pandemic, its purpose is to quickly develop practical countermeasures to disease outbreaks due to either natural causes or biowarfare attack.

The program has a number of aspects, such as finding ways to identify people who are infected before symptoms show, but one major facet is the Accelerated Manufacture of Pharmaceuticals (AMP) project.

[link to www.gizmag.com]